NCT Number: NCT02944916
Pilot Study Evaluating the Use of a New Device for Transanal Irrigation in Patient With Bowel Disorders
The study descripted of efficacy of IryPump®R Set in term of success of the procedure at each irrigation
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Patient is at least 18 years old,
- Patient having signed an informed consent
- Patient having neurologic or non neurologic bowel disorders, being initiated to TAI and practicing TAI with Peristeen® for the management of her/his bowel disorders, for at least 6 weeks, with satisfying results.
- Patient practicing TAI on the basis of 1 procedure/ week as a minimum or more frequently
- Patient capable to perform the procedure of transanal irrigation himself or with the help of a caregiver
- Patient having a mental capacity to participate to the study (i.e. to understand the study and to answer to the questions)
- Patient agrees to test IryPump® Set R for a time corresponding to 5 consecutive irrigations and a maximum of 4 weeks.
- Patient covered by social security
Exclusion criteria
- Patient with bowel obstruction
- Patient already participating in another clinical study or who have previously participated in this investigation,
- Pregnant or breast-feeding woman
Treatment and study plan
Primary outcomes
-
Success of the trans anal irrigation (TAI) procedure
Time frame: Duration of the study per patient will correspond to the realisation of 5 consecutive TAI in a maximum of 41 days of follow up
The patient will practice TAI following his usual frequency (depending on his intestinal transit). After each TAI, the patient will evaluate the success of the procedure (defined as satisfying output evacuation of the bowel according to the patient usual pattern in term of volume of water instilled and absence of leakages between 2 irrigations).
Sponsors and collaborators
Lead sponsor
BBraun Medical SAS
Industry
Registry information
Important dates
- Study start
- 2016
- Primary completion
- 2017
- Study completion
- 2017
- First posted
- Oct 26, 2016
- Registry last updated
- Jan 25, 2018
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Efficacy and Safety of a Solution for Endoscopic Mucosal Resection of Colonic Lesions
NCT06910514
Colonic Diseases, Colonic Neoplasms
Almería, Spain
View Trial DetailsClinical Trial of VISOR vs fURS for Upper Urinary Tract Stone
NCT07181759
Intraoperative Complications, Nephrolithiasis, Calcium Oxalate
View Trial Details